Inovio initiates dosing in Phase II segment of Covid-19 therapy trial
The Phase II part will enrol about 400 adults at up to 17 US sites. Credit: Viktor Forgacs on Unsplash.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
